Skip to main content
Equibles

Creative Planning

Position in GMAB — Genmab A/S

CIK 1540235 OVERLAND PARK, KS
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,273,571
+$91,642 QoQ
Shares Held
119,169
+0.5% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#55
of 292 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Creative Planning holds $457,365,908 across 219 Biotechnology names. GMAB ranks #36 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 127,672 $63,418,511
2 REGN
Regeneron Pharmaceuticals, Inc.
 36,949 $23,039,178
3 EXEL
Exelixis, Inc.
 270,292 $14,706,586
4 INCY
Incyte Corp
 110,664 $12,544,870
5 CYTK
Cytokinetics Inc
 141,939 $12,091,783
6 RVMD
Revolution Medicines, Inc.
 64,120 $12,008,393
7 ARGX
Argenx SE
 12,744 $11,823,500
8 BMRN
Biomarin Pharmaceutical Inc
 153,161 $8,763,872

All Filings in GMAB

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,273,571 119,169
2026-03-31 $3,181,929 118,596
2025-12-31 $4,021,956 130,583
2025-09-30 $3,553,088 115,849
2025-06-30 $1,345,626 65,132
2025-03-31 $1,140,769 58,262
2024-12-31 $2,229,500 106,828
2024-09-30 $1,156,148 47,422
2024-06-30 $504,331 20,069
2024-03-31 $1,101,584 36,830
2023-12-31 $724,104 22,742
2023-09-30 $923,333 26,179
2023-06-30 $756,322 19,898
2023-03-31 $638,332 16,905
2022-12-31 $637,268 15,037
2022-09-30 $395,327 12,304
2020-12-31 $208,260 5,122
2020-09-30 $1,901,340 51,935
2020-06-30 $1,752,485 51,711